Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival.
暂无分享,去创建一个
Melissa Bondy | Yuanyuan Xiao | Sanjay Shete | Mark Gilbert | Margaret Wrensch | Fu-Wen Liang | K. Aldape | M. Gilbert | S. Shete | R. Houlston | M. Wrensch | M. Bondy | J. Wiencke | G. Alexiou | Yuanyuan Xiao | U. Andersson | B. Melin | F. Hosking | G. Armstrong | T. Armstrong | Yanhong Liu | M. Scheurer | S. Tsavachidis | Yanhong Liu | Ulrika Andersson | Richard Houlston | C. Etzel | Ken Aldape | Georgina Armstrong | Beatrice S Melin | Carol J Etzel | Spyros Tsavachidis | John Wiencke | George Alexiou | Terri Armstrong | Michael Scheurer | Fay Hosking | Lindsay Robertson | Lindsay B. Robertson | F. Liang
[1] Heikki Mannila,et al. Evaluation of HapMap data in six populations of European descent , 2008, European Journal of Human Genetics.
[2] N. Banik,et al. Differentiation Decreased Telomerase Activity in Rat Glioblastoma C6 Cells and Increased Sensitivity to IFN-γ and Taxol for Apoptosis , 2007, Neurochemical Research.
[3] Gabriele Schackert,et al. Long-term survival with glioblastoma multiforme. , 2007, Brain : a journal of neurology.
[4] C. Marosi,et al. High expression of DNA topoisomerase IIalpha and Ki-67 antigen is associated with prolonged survival in glioblastoma patients. , 2002, European journal of cancer.
[5] Melissa Bondy,et al. Genome-wide association study identifies five susceptibility loci for glioma , 2009, Nature Genetics.
[6] J. Cairncross,et al. Which glioblastoma multiforme patient will become a long‐term survivor? A population‐based study , 1999, Annals of neurology.
[7] K. Aldape,et al. Molecular predictors in glioblastoma: toward personalized therapy. , 2008, Archives of neurology.
[8] K. Aldape,et al. Polymorphisms in the Interleukin-4 Receptor Gene are Associated with Better Survival in Patients with Glioblastoma , 2008, Clinical Cancer Research.
[9] H. Gronemeyer,et al. Co-resistance to retinoic acid and TRAIL by insertion mutagenesis into RAM , 2006, Oncogene.
[10] K. Aldape,et al. Association and Interactions between DNA Repair Gene Polymorphisms and Adult Glioma , 2009, Cancer Epidemiology Biomarkers & Prevention.
[11] Nathaniel Rothman,et al. Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies , 2004 .
[12] A. Morris,et al. Fine mapping versus replication in whole-genome association studies. , 2007, American journal of human genetics.
[13] JAMES C. Wang,et al. Cellular roles of DNA topoisomerases: a molecular perspective , 2002, Nature Reviews Molecular Cell Biology.
[14] J. Bruner,et al. γ-Radiation Sensitivity and Risk of Glioma , 2001 .
[15] R. Weil,et al. A Functional Polymorphism in the EGF Gene Is Found with Increased Frequency in Glioblastoma Multiforme Patients and Is Associated with More Aggressive Disease , 2004, Cancer Research.
[16] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[17] Y. Pommier,et al. Characterization of BTBD1 and BTBD2, two similar BTB-domain-containing Kelch-like proteins that interact with Topoisomerase I , 2002, BMC Genomics.
[18] P. Jeggo,et al. Genetic variants of NHEJ DNA ligase IV can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class switch recombination , 2002, Journal of medical genetics.
[19] J. Herman,et al. Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme , 2007, Journal of Neuro-Oncology.
[20] David J. Chen,et al. Suppression of nonhomologous end joining repair by overexpression of HMGA2. , 2009, Cancer research.
[21] Hongliang Liu,et al. Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma , 2008, Human mutation.
[22] Susan E Hodge,et al. Non-replication of association studies: “pseudo-failures” to replicate? , 2007, Genetics in Medicine.
[23] C. Muirhead,et al. Risks of brain tumour following treatment for cancer in childhood: Modification by genetic factors, radiotherapy and chemotherapy , 1998, International journal of cancer.
[24] J. Lahti,et al. Retinoic acid induces caspase-8 transcription via phospho-CREB and increases apoptotic responses to death stimuli in neuroblastoma cells. , 2008, Biochimica et biophysica acta.
[25] Thomas Meitinger,et al. Linkage disequilibrium patterns and tagSNP transferability among European populations. , 2005, American journal of human genetics.
[26] Z L Gokaslan,et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.
[27] Hong-Wen Deng,et al. Is Replication the Gold Standard for Validating Genome-Wide Association Findings? , 2008, PloS one.
[28] E. Holland,et al. Glioblastoma multiforme: the terminator. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[29] Jon Wakefield,et al. A Bayesian measure of the probability of false discovery in genetic epidemiology studies. , 2007, American journal of human genetics.
[30] Alexander R. Pico,et al. Variants in the CDKN2B and RTEL1 regions are associated with high grade glioma susceptibility , 2009, Nature Genetics.
[31] Robert Tibshirani,et al. A network model of a cooperative genetic landscape in brain tumors. , 2009, JAMA.
[32] J. Champoux. DNA topoisomerases: structure, function, and mechanism. , 2001, Annual review of biochemistry.
[33] Isabelle Cleynen,et al. The HMGA proteins: a myriad of functions (Review). , 2008, International journal of oncology.
[34] Yan Liu,et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. , 2006, Journal of the National Cancer Institute.
[35] Stephen C. West,et al. RTEL1 Maintains Genomic Stability by Suppressing Homologous Recombination , 2008, Cell.
[36] Luo Wang,et al. Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] D. Nelson,et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. , 1993, Journal of the National Cancer Institute.
[38] M. Sanson,et al. The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma. , 2007, Cancer genetics and cytogenetics.
[39] Y. Marie,et al. Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] B. Ponder,et al. Effect of germ-line genetic variation on breast cancer survival in a population-based study. , 2002, Cancer research.
[41] R. Mirimanoff,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[42] Harlan M Krumholz,et al. Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. , 2007, JAMA.
[43] Susan M. Chang,et al. Patterns of care for adults with newly diagnosed malignant glioma. , 2005, JAMA.
[44] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.